| Literature DB >> 31602106 |
Farzana Mansuri1, Anjali Mall1.
Abstract
BACKGROUND: Complications during pregnancy and childbirth remain a leading cause of illness and death among women of reproductive age in India. In the recent years, the concept of the WHO maternal near miss (MNM) has been adopted by the tertiary level hospitals as it has an added advantage of offering a large number of cases for intervention and for the evaluation of the maternal healthcare being provided by the health-care system.Entities:
Keywords: Maternal death; maternal near miss; maternal outcomes; tertiary level
Year: 2019 PMID: 31602106 PMCID: PMC6776947 DOI: 10.4103/ijcm.IJCM_267_18
Source DB: PubMed Journal: Indian J Community Med ISSN: 0970-0218
Distance of residence from the hospital for both the groups
| Place of residence | ||
|---|---|---|
| MNM ( | Maternal death ( | |
| Within 10 (km) | 61 (24.70) | 16 (20.25) |
| 10-30 (km) | 60 (24.30) | 19 (24.05) |
| 30-50 (km) | 36 (14.57) | 13 (16.46) |
| >50 (km) | 90 (36.43) | 31 (39.24) |
χ2=0.7693, P=0.856791. MNM: Maternal near miss
Severe maternal outcomes and near miss indicators
| Overall near miss indicators (live births=21,491) | |
|---|---|
| Indicators | Ratio/Percentage |
| Severe maternal outcome ratio (per 1000 live births) ( | 15.17 |
| MNM ratio (per 1000 live births) ( | 11.49 |
| MNM mortality ratio | 3.1:1 |
| Mortality index (maternal death=79) (%) | 24.23 |
MNM: Maternal near miss
Process and outcome indicators for five potentially life-threatening conditions
| Indicators | |
|---|---|
| Prevention of postpartum hemorrhage ( | |
| Oxytocin use | 288 (88.33) |
| Use of any uterotonic (including oxytocin) | 322 (98.77) |
| Treatment of severe postpartum hemorrhage ( | |
| Oxytocin use | 60 (82.19) |
| Ergometrine | 30 (41.10) |
| Misoprostol | 40 (54.79) |
| Tranexamic acid | 41 (56.16) |
| Artery ligation | 4 (5.48) |
| Hysterectomy | 18 (24.66) |
| Packing | 25 (34.25) |
| Proportion of cases with severe maternal outcome | 73 (22.39) |
| Mortality | 12 (16.44) |
| Anticonvulsants for eclampsia ( | |
| Magnesium sulfate | 96 (100) |
| Another anticonvulsant | 51 (53.13) |
| Proportion of cases with severe maternal outcome | 96 (29.45) |
| Mortality | 18 (18.75) |
| Prevention of cesarean section-related infection ( | |
| Prophylactic antibiotic during cesarean section | 113 (100) |
| Treatment for sepsis ( | |
| Parenteral therapeutic antibiotics | 51 (100) |
| Proportion of cases with severe maternal outcome | 51 (15.64) |
| Mortality | 35 (68.63) |
| Women with rupture uterus ( | |
| Laparotomy | 14 (93.33) |
| Proportion of cases with severe maternal outcome | 15 (4.60) |
| Mortality | 6 (40) |